Howard Y. Chang

Howard Y. Chang

Direttore Tecnico/Scientifico/R&S presso AMGEN INC.
Health Technology
Commercial Services
Consumer Services

Profilo

Howard Y.
Chang
is the founder of Accent Therapeutics, Inc., founded in 2017.
Dr. Chang is also the founder of Epinomics, Inc.,Cartography Biosciences, Inc.,Orbital Therapeutics, Inc...
Dr. Chang currently holds the position of Chief Scientific Officer & SVP-Global Research at Amgen, Inc. since 2024.
Dr. Chang is a member of the National Academy of Sciences, the American Academy of Arts & Sciences, and the National Academy of Medicine (United States).
Dr. Chang completed undergraduate education at Harvard University, earned a doctorate from the Massachusetts Institute of Technology, and earned a doctorate from Harvard Medical School.

Posizioni attive di Howard Y. Chang

SocietàPosizioneInizio
AMGEN INC. Direttore Tecnico/Scientifico/R&S 16/12/2024
Fondatore -
Fondatore -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Howard Y. Chang

SocietàPosizioneFine
Fondatore -
Fondatore -
Vedi nel dettaglio l'esperienza di Howard Y. Chang

Formazione di Howard Y. Chang

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

92

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Consumer Services

Finance

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Howard Y. Chang